BCS1L (Mitochondrial chaperone BCS1) is a conserved AAA-type ATPase that functions as a dedicated assembly factor for mitochondrial respiratory chain Complex III (cytochrome bc1 complex). BCS1L forms a heptameric ring embedded in the mitochondrial inner membrane and uses ATP hydrolysis to translocate the fully folded Rieske iron-sulfur protein (UQCRFS1) from the matrix across the inner membrane into the intermembrane space (IMS), where it is incorporated into pre-Complex III. This is an essential late step in CIII biogenesis. BCS1L is NOT a structural subunit of the mature Complex III; it is an assembly factor that acts transiently during biogenesis. The protein has a single N-terminal transmembrane helix, a BCS1-specific middle domain, and a C-terminal AAA ATPase domain. It also interacts with LETM1 and influences LETM1 complex formation. Loss-of-function mutations in BCS1L cause a spectrum of diseases including GRACILE syndrome (growth retardation, aminoaciduria, cholestasis, iron overload, lactic acidosis, and early death), Bjornstad syndrome (sensorineural hearing loss and pili torti), and mitochondrial complex III deficiency nuclear type 1 (MC3DN1). BCS1L is the human ortholog of yeast Bcs1.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0032979
protein insertion into mitochondrial inner membrane from matrix
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: BCS1L translocates the folded Rieske iron-sulfur protein (UQCRFS1) from the mitochondrial matrix across the inner membrane for incorporation into pre-Complex III. This function is conserved from yeast Bcs1 to human BCS1L. The IBA annotation to GO:0032979 (protein insertion into mitochondrial inner membrane from matrix) accurately captures this core translocase function. The deep research review confirms BCS1L as an "ATP-driven translocase/chaperone that translocates the folded Rieske Fe-S protein (UQCRFS1 / RISP) from the matrix into the IMS" (file:human/BCS1L/BCS1L-deep-research-falcon.md). UniProt describes it as a "Chaperone necessary for the incorporation of Rieske iron-sulfur protein UQCRFS1 into the mitochondrial respiratory chain complex III" (PMID:11528392, PMID:9878253).
Reason: This IBA annotation is well-supported and at the correct level of specificity. BCS1L's primary molecular mechanism is the ATP-driven translocation of the folded UQCRFS1 from the matrix side into/through the inner membrane. This is the defining translocase activity of BCS1L and is phylogenetically conserved from yeast to human. The annotation is well-placed: BCS1L does insert a protein (UQCRFS1) into or through the mitochondrial inner membrane from the matrix.
Supporting Evidence:
file:human/BCS1L/BCS1L-deep-research-falcon.md
ATP-driven translocase/chaperone that translocates the folded Rieske Fe-S protein (UQCRFS1 / RISP) from the matrix into the IMS
PMID:9878253
In yeast, BCS1 is involved mainly in the assembly of complex III
|
|
GO:0034551
mitochondrial respiratory chain complex III assembly
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: BCS1L is a well-established assembly factor for mitochondrial Complex III. The phylogenetic inference from yeast Bcs1 through to human BCS1L is strongly supported. UniProt describes BCS1L as a "Chaperone necessary for the incorporation of Rieske iron-sulfur protein UQCRFS1 into the mitochondrial respiratory chain complex III" (PMID:11528392, PMID:9878253). PMID:9878253 identified BCS1L as the human ortholog of yeast BCS1, "involved mainly in the assembly of complex III." Reactome also curates BCS1L under Complex III assembly (R-HSA-9865881). This is the core biological process of BCS1L.
Reason: Mitochondrial respiratory chain complex III assembly is the core biological process for BCS1L. This IBA annotation is at the correct level of specificity and is supported by extensive experimental and phylogenetic evidence. BCS1L inserts the Rieske Fe-S protein into pre-CIII, which is an essential step in CIII assembly.
Supporting Evidence:
PMID:9878253
In yeast, BCS1 is involved mainly in the assembly of complex III
Reactome:R-HSA-9865881
Assembly of the cytochrome c (cytochrome bc1) reductase (Complex III) was mainly investigated in yeast
file:human/BCS1L/BCS1L-deep-research-falcon.md
Essential assembly factor for mitochondrial Complex III (cytochrome bc1); required for formation of catalytically competent CIII and thus for the Q-cycle electron transfer
|
|
GO:0005743
mitochondrial inner membrane
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: BCS1L is anchored in the mitochondrial inner membrane via a single N-terminal transmembrane helix (residues 16-32 per UniProt). UniProt annotates BCS1L to "Mitochondrion inner membrane; Single-pass membrane protein" (PMID:18628306, PMID:9878253). The heptameric BCS1L ring spans the inner membrane with its AAA domain projecting into the matrix. The IBA annotation correctly captures this well-established localization.
Reason: Mitochondrial inner membrane localization is universally agreed upon for BCS1L. The protein has a single transmembrane helix and the UniProt record confirms inner membrane localization with experimental evidence from multiple studies. The IBA annotation is phylogenetically well-supported and at the correct level of specificity.
Supporting Evidence:
PMID:18628306
LETM1 is a mitochondrial inner-membrane protein ... LETM1 was co-precipitated with BCS1L
PMID:9878253
Mitochondrial targeting of the human gene products, suggested by computer analysis of the protein sequences, was confirmed by an in vitro import and protease-protection assay
|
|
GO:0000166
nucleotide binding
|
IEA
GO_REF:0000043 |
ACCEPT |
Summary: BCS1L contains a conserved AAA ATPase domain with a P-loop (Walker A motif) at residues 230-237 that binds ATP (UniProt BINDING annotation). The IEA annotation to nucleotide binding (GO:0000166) via UniProt keyword mapping is technically correct but very broad. More specific ATP binding (GO:0005524) and ATP hydrolysis activity (GO:0016887) annotations are already present.
Reason: While very general, this IEA annotation is technically correct. BCS1L is an AAA-type ATPase that binds nucleotides (specifically ATP). More specific annotations are present in the set (GO:0005524 ATP binding, GO:0016887 ATP hydrolysis activity). It is acceptable for an IEA to be broader than what is established by more specific evidence.
|
|
GO:0005524
ATP binding
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: BCS1L contains a well-characterized AAA ATPase domain with a P-loop/Walker A motif (residues 230-237) that binds ATP (UniProt). The InterPro domains IPR003959 (ATPase_AAA_core) and IPR003960 (ATPase_AAA_CS) confirm ATP binding capability. Cryo-EM structures demonstrate ATP/ADP cycling in the heptameric ring during the translocation mechanism (file:human/BCS1L/BCS1L-deep-research-falcon.md). The UniProt EC number is 3.6.1.- (by similarity to yeast P32839).
Reason: ATP binding is a well-established property of BCS1L as an AAA-type ATPase. The annotation is supported by domain architecture, structural data, and evolutionary conservation. This is a core molecular function of BCS1L.
Supporting Evidence:
file:human/BCS1L/BCS1L-deep-research-falcon.md
ATP binding opens a cavity to accommodate the folded, Fe2S2-containing UQCRFS1; ATP hydrolysis drives conformational changes that gate and release the client
|
|
GO:0005743
mitochondrial inner membrane
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: This IEA annotation from UniProt Subcellular Location vocabulary mapping is consistent with all other evidence. UniProt explicitly annotates BCS1L to the mitochondrion inner membrane as a single-pass membrane protein (PMID:18628306, PMID:9878253). This duplicates the IBA annotation (GO_REF:0000033) for the same term but via independent evidence.
Reason: Consistent with the IBA annotation and the well-established inner membrane localization of BCS1L. Duplicate annotations from different evidence sources are acceptable. UniProt's subcellular location mapping is correct here.
|
|
GO:0016787
hydrolase activity
|
IEA
GO_REF:0000043 |
ACCEPT |
Summary: BCS1L hydrolyzes ATP (EC 3.6.1.-) as part of its AAA-type ATPase mechanism. Hydrolase activity (GO:0016787) is the correct broad parent for this. The annotation from UniProt keyword mapping is technically correct but very broad. More specific ATP hydrolysis activity (GO:0016887) is already present.
Reason: While very general, this IEA annotation is technically correct. BCS1L is an ATPase that catalyzes the hydrolysis of ATP. More specific annotations (GO:0016887 ATP hydrolysis activity) are present. It is acceptable for IEA annotations to be broader than what is established by more specific evidence.
|
|
GO:0016887
ATP hydrolysis activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: BCS1L is a member of the AAA ATPase family and uses ATP hydrolysis to power the translocation of the folded Rieske protein across the inner membrane. UniProt assigns EC 3.6.1.- (by similarity to yeast Bcs1, P32839). The deep research review describes an "ATP/ADP-dependent conformational cycle" where "ATP hydrolysis drives conformational changes that gate and release the client to the IMS" (file:human/BCS1L/BCS1L-deep-research-falcon.md). This is a core molecular function of BCS1L.
Reason: ATP hydrolysis activity is a core molecular function of BCS1L. It uses ATP hydrolysis to drive translocation of UQCRFS1 across the inner membrane. The annotation is well-supported by domain architecture (AAA ATPase domain), EC classification, and mechanistic studies. Per the GO note on this term, BCS1L should also ideally be annotated to a child of ATP-dependent activity (GO:0140657) to capture its overall function.
Supporting Evidence:
file:human/BCS1L/BCS1L-deep-research-falcon.md
ATP hydrolysis drives conformational changes that gate and release the client to the IMS while preserving membrane integrity
|
|
GO:0034551
mitochondrial respiratory chain complex III assembly
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: This IEA annotation via ARBA machine learning correctly identifies the core biological process of BCS1L. The annotation is consistent with the IBA and IMP annotations for the same term already present, and is well-supported by all evidence reviewed.
Reason: The ARBA-derived IEA annotation is correct. CIII assembly is the core function of BCS1L. This is redundant with the IBA and IMP annotations but not incorrect. Multiple independent evidence lines supporting the same annotation are acceptable.
|
|
GO:0005739
mitochondrion
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: BCS1L is a mitochondrial protein. This broader CC annotation (mitochondrion rather than mitochondrial inner membrane) is technically correct. More specific inner membrane annotations are already present from IBA and IEA evidence.
Reason: Mitochondrial localization is universally agreed upon. While the more specific inner membrane annotation is also present, this broader IEA annotation is acceptable as it provides independent automated evidence for the mitochondrial localization.
|
|
GO:0005739
mitochondrion
|
HTP
PMID:34800366 Quantitative high-confidence human mitochondrial proteome an... |
ACCEPT |
Summary: BCS1L was identified as part of the high-confidence human mitochondrial proteome by Morgenstern et al. (2021, PMID:34800366), a comprehensive quantitative proteomics study. This HTP evidence provides independent experimental confirmation of mitochondrial localization via mass spectrometry-based identification.
Reason: The HTP annotation is based on large-scale quantitative proteomics and is consistent with all other evidence for BCS1L mitochondrial localization. While less specific than the inner membrane annotation, it provides independent experimental support.
Supporting Evidence:
PMID:34800366
Quantitative high-confidence human mitochondrial proteome
|
|
GO:0005739
mitochondrion
|
IDA
PMID:9878253 Identification and characterization of human cDNAs specific ... |
ACCEPT |
Summary: Petruzzella et al. (1998, PMID:9878253) confirmed mitochondrial targeting of BCS1L using an in vitro import and protease-protection assay. The abstract states: "Mitochondrial targeting of the human gene products, suggested by computer analysis of the protein sequences, was confirmed by an in vitro import and protease-protection assay." This is direct experimental evidence for mitochondrial localization.
Reason: This is strong IDA evidence from the founding characterization of human BCS1L. The in vitro import and protease-protection assay directly demonstrates that BCS1L is imported into mitochondria. This is consistent with all other localization data.
Supporting Evidence:
PMID:9878253
Mitochondrial targeting of the human gene products, suggested by computer analysis of the protein sequences, was confirmed by an in vitro import and protease-protection assay
|
|
GO:0005515
protein binding
|
IPI
PMID:18628306 Characterization of the mitochondrial protein LETM1, which m... |
MARK AS OVER ANNOTATED |
Summary: This IPI annotation is based on the physical interaction between BCS1L and LETM1 (UniProtKB:O95202), identified by Tamai et al. (2008, PMID:18628306). The abstract states: "LETM1 was co-precipitated with BCS1L and formation of the LETM1 complex depended on BCS1L levels, suggesting that BCS1L stimulates the assembly of the LETM1 complex." While the interaction is biologically meaningful, the term 'protein binding' (GO:0005515) is uninformative per GO curation guidelines.
Reason: The term 'protein binding' (GO:0005515) is uninformative per GO curation guidelines. The BCS1L-LETM1 interaction is experimentally validated and biologically interesting, but this generic MF term does not convey any specific information about BCS1L's actual molecular function. The biological significance of this interaction is better captured by the process annotation for mitochondrion organization (GO:0007005). A more informative MF annotation would describe BCS1L's translocase/chaperone activity.
Supporting Evidence:
PMID:18628306
LETM1 was co-precipitated with BCS1L and formation of the LETM1 complex depended on BCS1L levels, suggesting that BCS1L stimulates the assembly of the LETM1 complex
|
|
GO:0034551
mitochondrial respiratory chain complex III assembly
|
IMP
PMID:18628306 Characterization of the mitochondrial protein LETM1, which m... |
ACCEPT |
Summary: Tamai et al. (2008, PMID:18628306) demonstrated that BCS1L knockdown caused "disassembly of the respiratory chains." The abstract states: "BCS1L knockdown caused disassembly of the respiratory chains as well as LETM1 downregulation and induced distinct changes in mitochondrial morphology." Additionally, the R155P (MC3DN1) variant was characterized and found to abolish interaction with LETM1. This IMP evidence from mutant/knockdown phenotype confirms BCS1L's role in CIII assembly.
Reason: This is strong IMP evidence demonstrating that loss of BCS1L function causes disassembly of the respiratory chains, including Complex III. This directly supports BCS1L's role as a CIII assembly factor. Combined with the IBA and IEA annotations, this provides multiple independent evidence lines for the core function.
Supporting Evidence:
PMID:18628306
BCS1L knockdown caused disassembly of the respiratory chains as well as LETM1 downregulation and induced distinct changes in mitochondrial morphology
|
|
GO:0005739
mitochondrion
|
IDA
PMID:18628306 Characterization of the mitochondrial protein LETM1, which m... |
ACCEPT |
Summary: Tamai et al. (2008, PMID:18628306) studied BCS1L localization in HeLa cells and confirmed it is a mitochondrial inner-membrane protein that interacts with LETM1. The title itself describes BCS1L as "the mitochondrial protein LETM1...interacts with the AAA-ATPase BCS1L" and the study performed subcellular localization experiments placing BCS1L in mitochondria.
Reason: Independent IDA evidence from Tamai et al. (2008) confirming mitochondrial localization of BCS1L. Consistent with all other evidence. Multiple IDA annotations from different studies for the same term are acceptable.
Supporting Evidence:
PMID:18628306
LETM1 is a mitochondrial inner-membrane protein ... LETM1 was co-precipitated with BCS1L
|
|
GO:0007005
mitochondrion organization
|
IMP
PMID:18628306 Characterization of the mitochondrial protein LETM1, which m... |
KEEP AS NON CORE |
Summary: Tamai et al. (2008, PMID:18628306) demonstrated that BCS1L knockdown caused "distinct changes in mitochondrial morphology" and affected LETM1 levels and complex formation. LETM1 knockdown itself caused "mitochondrial swelling and cristae disorganization." Since BCS1L knockdown leads to LETM1 downregulation, and LETM1 is required for maintaining mitochondrial tubular networks, BCS1L indirectly affects mitochondrion organization. However, this is a secondary pleiotropic consequence of BCS1L loss rather than a core function. BCS1L's core function is CIII assembly, and disruption of respiratory chain complexes leads to downstream mitochondrial morphology defects.
Reason: While BCS1L knockdown does cause changes in mitochondrial morphology, this is a downstream consequence of respiratory chain disassembly and LETM1 downregulation, not a core direct function of BCS1L. BCS1L's primary role is as a CIII assembly factor and UQCRFS1 translocase. The mitochondrion organization phenotype is a pleiotropic secondary effect. The annotation is not wrong but should be flagged as non-core.
Supporting Evidence:
PMID:18628306
BCS1L knockdown caused disassembly of the respiratory chains as well as LETM1 downregulation and induced distinct changes in mitochondrial morphology
|
|
GO:0032981
mitochondrial respiratory chain complex I assembly
|
IMP
PMID:18628306 Characterization of the mitochondrial protein LETM1, which m... |
MARK AS OVER ANNOTATED |
Summary: Tamai et al. (2008, PMID:18628306) reported that BCS1L knockdown caused "disassembly of the respiratory chains." This broad statement encompasses Complex I, III, and IV. However, BCS1L is specifically a Complex III assembly factor that translocates the Rieske Fe-S protein. Loss of BCS1L directly impairs CIII assembly, and since respiratory chain complexes can form supercomplexes (respirasomes), loss of CIII can secondarily destabilize CI and CIV. There is no evidence that BCS1L directly participates in Complex I assembly. The CI assembly defect observed upon BCS1L knockdown is an indirect pleiotropic consequence.
Reason: BCS1L is not a Complex I assembly factor. It is a Complex III assembly factor. The observed effect on Complex I assembly upon BCS1L knockdown is a secondary consequence of CIII destabilization, which in turn destabilizes supercomplexes containing CI. Annotating BCS1L to CI assembly conflates indirect downstream effects with direct function. This is an over-annotation that could mislead users about BCS1L's actual role.
Supporting Evidence:
PMID:18628306
BCS1L knockdown caused disassembly of the respiratory chains
file:human/BCS1L/BCS1L-deep-research-falcon.md
Essential assembly factor for mitochondrial Complex III (cytochrome bc1); required for formation of catalytically competent CIII
|
|
GO:0033617
mitochondrial respiratory chain complex IV assembly
|
IMP
PMID:18628306 Characterization of the mitochondrial protein LETM1, which m... |
MARK AS OVER ANNOTATED |
Summary: Tamai et al. (2008, PMID:18628306) reported that BCS1L knockdown caused "disassembly of the respiratory chains." This broad disassembly phenotype was interpreted as affecting Complex IV assembly as well. However, BCS1L is specifically a Complex III assembly factor. There is no evidence that BCS1L directly participates in Complex IV biogenesis. The CIV assembly defect observed upon BCS1L knockdown is an indirect consequence of CIII destabilization, since CI, CIII, and CIV form supercomplexes and loss of one component can destabilize others. This is analogous to how SURF1 (a CIV assembly factor) mutations affect other complexes secondarily.
Reason: BCS1L is not a Complex IV assembly factor. It is a Complex III assembly factor. The observed effect on Complex IV assembly upon BCS1L knockdown is a secondary consequence of CIII destabilization affecting supercomplex stability. Annotating BCS1L to CIV assembly conflates indirect downstream effects with direct function. This is an over-annotation analogous to the CI assembly annotation.
Supporting Evidence:
PMID:18628306
BCS1L knockdown caused disassembly of the respiratory chains
file:human/BCS1L/BCS1L-deep-research-falcon.md
Essential assembly factor for mitochondrial Complex III (cytochrome bc1)
|
|
GO:0045275
respiratory chain complex III
|
TAS
PMID:9878253 Identification and characterization of human cDNAs specific ... |
REMOVE |
Summary: This TAS annotation places BCS1L as part_of "respiratory chain complex III" (GO:0045275). The GOA file uses the qualifier "part_of." GO:0045275 is defined as "A protein complex that transfers electrons from ubiquinol to cytochrome c and translocates two protons across a membrane." BCS1L is NOT a structural subunit of the mature Complex III. It is an assembly factor that transiently associates with pre-Complex III during biogenesis but is not a component of the final holoenzyme. The original paper (PMID:9878253) describes BCS1 as "involved in the assembly of complex III" in yeast, not as a subunit. UniProt describes BCS1L as a "Chaperone necessary for the incorporation of Rieske iron-sulfur protein UQCRFS1 into the mitochondrial respiratory chain complex III," clearly distinguishing it from a structural subunit. The Reactome pathway (R-HSA-9865881) places BCS1L as an assembly factor, not as a component of the mature complex.
Reason: BCS1L is NOT a structural subunit of respiratory chain complex III. It is a transient assembly factor that facilitates UQCRFS1 incorporation into pre-CIII but is not part of the mature complex. The "part_of" qualifier in GOA makes this annotation explicitly incorrect -- BCS1L is not part of the CIII holoenzyme. The founding paper (PMID:9878253) describes BCS1 as involved in "assembly" of CIII, not as a component. This annotation likely arose from confusion between an assembly factor and a structural subunit. The correct annotations for BCS1L are to CIII assembly (GO:0034551, already present) and to the mitochondrial inner membrane (GO:0005743, already present). This parallels the SURF1 case where annotation to "respiratory chain complex" was modified because SURF1 is an assembly factor, not a structural subunit.
Supporting Evidence:
PMID:9878253
In yeast, BCS1 is involved mainly in the assembly of complex III
Reactome:R-HSA-9865881
Mutations in nuclear genes coding for subunits of Complex III, as well as assembly factors, can cause complex III deficiency
file:human/BCS1L/BCS1L-deep-research-falcon.md
BCS1L is best understood as a dedicated AAA+ protein translocase that recognizes and translocates folded, cofactor-loaded UQCRFS1 across/into the IMS side of pre-complex III
|
|
GO:0008320
protein transmembrane transporter activity
|
ISS
PMID:37821516 A concerted ATPase cycle of the protein transporter AAA-ATPa... |
NEW |
Summary: BCS1L functions as an ATP-driven transmembrane translocase that moves the folded Rieske Fe-S protein (UQCRFS1) from the matrix across the inner membrane into the intermembrane space. This translocase function is conserved from yeast Bcs1 to human BCS1L. GO:0008320 (protein transmembrane transporter activity) is defined as "Enables the transfer of a protein from one side of a membrane to the other." This accurately describes BCS1L's core molecular function. The deep research review describes BCS1L as a "specialized transmembrane protein translocase for a folded cofactor-containing substrate" with an "ATP-coupled airlock-like gating mechanism." This annotation is missing from the current set and would capture the specific MF of BCS1L that goes beyond simple ATP hydrolysis.
Reason: The current annotation set lacks a specific MF annotation capturing BCS1L's translocase activity. While ATP hydrolysis (GO:0016887) and ATP binding (GO:0005524) are present, these describe the energy source, not the actual function. GO:0008320 (protein transmembrane transporter activity) would capture what BCS1L actually does with the energy from ATP hydrolysis: it translocates a protein (UQCRFS1) across the inner membrane. This is more informative than the generic protein binding currently annotated.
Supporting Evidence:
PMID:37821516
Bcs1, a homo-heptameric transmembrane AAA-ATPase, facilitates folded Rieske iron-sulfur protein translocation across the inner mitochondrial membrane
file:human/BCS1L/BCS1L-deep-research-falcon.md
BCS1L is best understood as a dedicated AAA+ protein translocase that recognizes and translocates folded, cofactor-loaded UQCRFS1 across/into the IMS side of pre-complex III. This specialized role distinguishes it from general chaperones
|
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
Plan status: Objectives 1–6 were addressed via targeted literature search and evidence extraction; key recent (2023–2024) advances and foundational mechanisms were compiled, and a summary artifact was prepared. The final objective is fulfilled below with a comprehensive, cited report.
Comprehensive research report: Human BCS1L (UniProt Q9Y276)
Gene/protein verification and identity
- Symbol/gene name: BCS1L (also known as BCS1). Organism: Homo sapiens. Protein: mitochondrial chaperone/assembly factor BCS1L, a member of the AAA+ ATPase family, BCS1 subfamily, with an N-terminal transmembrane segment, a BCS1-specific middle domain, and a C‑terminal AAA ATPase domain. These features align with UniProt Q9Y276 and literature describing a heptameric, inner-membrane-anchored AAA+ ATPase that powers client translocation for complex III assembly (notably UQCRFS1/Rieske). (ros2025bluntingmycfunction pages 11-16, ros2025bluntingmycfunction pages 7-11)
Key concepts and definitions (current understanding)
- Primary role: BCS1L is an essential mitochondrial complex III (cytochrome bc1) assembly factor. It functions as an ATP-driven translocase/chaperone to move the fully folded Rieske iron–sulfur protein (RISP; UQCRFS1) from the matrix side into the intermembrane space (IMS) and deliver it to pre-complex III for maturation into a catalytically competent dimer. This step is required to complete CIII biogenesis and enable the Q-cycle of electron transfer from ubiquinol to cytochrome c. (ros2025bluntingmycfunction pages 11-16, ros2025bluntingmycfunction pages 7-11, ros2025bluntingmycfunction pages 16-19)
- Molecular mechanism: Recent cryo-EM–guided models indicate an ATP/ADP cycling “airlock”-like mechanism. ATP binding opens a cavity to accommodate the folded, Fe2S2-containing UQCRFS1; ATP hydrolysis drives conformational changes that gate and release the client to the IMS while preserving membrane integrity. BCS1L thus acts as an ATP-fueled transmembrane protein translocase specific for the Rieske subunit. (ros2025bluntingmycfunction pages 11-16)
- Subcellular localization and assembly state: BCS1L is embedded in the mitochondrial inner membrane via its N-terminal TM segment and assembles into a heptameric AAA+ ring that operates on the matrix side to engage folded UQCRFS1 before transferring it across/into the IMS-facing side of pre-complex III. (ros2025bluntingmycfunction pages 11-16)
Pathway context and interacting components
- Respiratory chain context: CIII is an 11-subunit dimeric complex that re-oxidizes ubiquinol (QH2) and reduces cytochrome c as part of the Q-cycle. Correct insertion and processing of the Rieske iron–sulfur protein (UQCRFS1) is a defining late step in CIII assembly that depends on BCS1L function. Perturbation of BCS1L impairs CIII assembly/activity and disrupts electron transfer, with downstream bioenergetic and metabolic consequences. (ros2025bluntingmycfunction pages 7-11)
Recent developments and latest research (2023–2024 priority)
- Mechanistic/structural advances: Contemporary structural work summarized in 2024–2025 sources proposes the ATP-coupled “airlock” model for BCS1L’s translocation of folded UQCRFS1, integrating cryo-EM snapshots of ATP- versus ADP-bound states with a gated client-handling cycle. These updates refine the classical view of BCS1L as an AAA+ chaperone into a specialized transmembrane protein translocase for a folded cofactor-containing substrate. (ros2025bluntingmycfunction pages 11-16) [Mechanism referenced therein; see also Nature Communications 2023 DOI: https://doi.org/10.1038/s41467-023-41806-5]
- Preclinical gene therapy in Bcs1l p.S78G mice (GRACILE model): In complex III–deficient Bcs1l p.S78G knock-in mice, a single intraperitoneal injection of rAAV expressing wild-type Bcs1l under a hepatocyte-specific promoter prevented hepatopathy, restored hepatic complex III assembly/activity, improved hypoglycemia and growth, normalized liver fuel use, and approximately doubled median survival, despite continued extrahepatic disease. Reported data include ~15-fold hepatic Bcs1l mRNA induction, restoration of hepatic complex III activity to ~74% of wild-type, and median survival around 58 days for AAT-driven hepatic expression cohorts. rAAV episomal dilution limited durability; PiggyBac-aided integration raised later hepatic expression but did not further extend survival. (bioRxiv Nov 2024, https://doi.org/10.1101/2024.09.23.612616; 2025 preprint, https://doi.org/10.1101/2025.09.23.677965) (banerjee2024hepaticmitochondrialrespiration pages 1-4, banerjee2025hepaticgenereplacement pages 1-5, banerjee2025hepaticgenereplacement pages 5-8)
- Thermoregulation insight and AOX rescue: The same GRACILE model revealed hypothermia, inflamed/inactive brown adipose tissue, and sensory innervation defects; increasing cellular respiration with a transgenic alternative oxidase (AOX) prevented hypothermia. Housing at thermoneutrality (35°C) alleviated metabolic stress and hepatocyte senescence, highlighting systemic physiology secondary to hepatic respiratory dysfunction. (bioRxiv Nov 2024, https://doi.org/10.1101/2024.09.23.612616) (banerjee2024hepaticmitochondrialrespiration pages 1-4)
Human genetics, phenotypes, and disease spectrum
- Spectrum of BCS1L-related disease: Pathogenic variants in BCS1L are among the most common nuclear causes of mitochondrial complex III deficiency. Clinical phenotypes include GRACILE syndrome—a severe neonatal disorder caused by a homozygous Finnish founder mutation c.A232G (p.Ser78Gly)—and Björnstad syndrome, among others, with heterogeneous systemic involvement. (ros2025bluntingmycfunction pages 16-19)
- GRACILE syndrome features: Growth restriction, lactic acidosis, hepatic iron overload/hepatopathy, proximal tubulopathy, hypoglycemia, and early death characterize the severe end of the spectrum; mouse knock-in models recapitulate postnatal-onset decline in hepatic complex III assembly and bioenergetics, establishing a presymptomatic therapeutic window. Diet and gene-modulatory interventions (e.g., ketogenic diet, MYC modulation) have shown disease-modifying effects in mice, underscoring pathway tractability. (ros2025bluntingmycfunction pages 16-19, ros2025bluntingmycfunction pages 7-11)
Current applications and real-world implementations
- Preclinical gene replacement: Hepatocyte-directed rAAV Bcs1l replacement constitutes a concrete, reproducible application with disease-modifying effects in a multiorgan mitochondrial disease model. Benefits include prevention of hepatopathy, restoration of hepatic complex III function, improved systemic metabolism, and extended survival. Limitations include incomplete correction in extrahepatic tissues and waning expression from episomal vectors. (bioRxiv Nov 2024, https://doi.org/10.1101/2024.09.23.612616; 2025 preprint, https://doi.org/10.1101/2025.09.23.677965) (banerjee2024hepaticmitochondrialrespiration pages 1-4, banerjee2025hepaticgenereplacement pages 1-5, banerjee2025hepaticgenereplacement pages 5-8)
- Systems physiology insights: Thermoregulation defects in Bcs1l p.S78G mice were prevented by AOX-driven respiration and improved by thermoneutral housing, informing supportive care hypotheses for mitochondrial disease (e.g., careful temperature management). (bioRxiv Nov 2024, https://doi.org/10.1101/2024.09.23.612616) (banerjee2024hepaticmitochondrialrespiration pages 1-4)
Expert opinions and authoritative synthesis
- State-of-the-art view: BCS1L is best understood as a dedicated AAA+ protein translocase that recognizes and translocates folded, cofactor-loaded UQCRFS1 across/into the IMS side of pre-complex III. This specialized role distinguishes it from general chaperones and positions it as the key gatekeeper of a late, rate-determining assembly step in CIII biogenesis. Disruption leads to a cascade of tissue-selective vulnerabilities, with the liver as a critical hub of systemic energy homeostasis in severe pediatric presentations. (ros2025bluntingmycfunction pages 11-16, ros2025bluntingmycfunction pages 7-11, ros2025bluntingmycfunction pages 16-19)
- Translational outlook: The hepatocyte-first gene replacement strategy demonstrates meaningful disease modification and suggests that multi-tissue or sequential organ-targeted delivery—or durable genomic integration—may be required for sustained benefit in systemic disease. Modulating downstream stress responses (e.g., MYC activity) and environmental variables (thermoneutrality) may further expand therapeutic windows. (banerjee2024hepaticmitochondrialrespiration pages 1-4, banerjee2025hepaticgenereplacement pages 5-8, ros2025bluntingmycfunction pages 7-11)
Relevant statistics and data points (from recent studies)
- Hepatocyte-directed rAAV Bcs1l in Bcs1l p.S78G mice: ~15-fold hepatic Bcs1l mRNA at postnatal day 28; hepatic complex III activity restored to ~74% of WT; prevention of hepatopathy; improved glucose homeostasis and growth; median survival extended to ~58 days (AAT promoter cohort), with broader expression (CAG) modestly increasing survival further. (banerjee2025hepaticgenereplacement pages 1-5, banerjee2025hepaticgenereplacement pages 5-8)
- Thermoregulation: AOX transgene normalized core temperature in CIII-deficient mice; thermoneutral housing (35°C) relieved metabolic stress and hepatocyte senescence, implicating hepatic respiration in whole-body temperature control. (banerjee2024hepaticmitochondrialrespiration pages 1-4)
Embedded quick-reference artifact
| Aspect | Summary | Evidence (Context IDs) |
|---|---|---|
| Identity / Family / Domains | AAA+ ATPase, BCS1 subfamily; N-terminal transmembrane helix, BCS1-specific domain, C-terminal AAA ATPase domain. | (ros2025bluntingmycfunction pages 11-16, ros2025bluntingmycfunction pages 7-11) |
| Subcellular localization | Mitochondrial inner membrane; assembles as a heptameric ring that spans matrix/inner-membrane and operates to move clients into the intermembrane space. | (ros2025bluntingmycfunction pages 11-16, ros2025bluntingmycfunction pages 7-11) |
| Primary function | ATP-driven translocase/chaperone that translocates the folded Rieske Fe-S protein (UQCRFS1 / RISP) from the matrix into the IMS for incorporation into pre-complex III. | (ros2025bluntingmycfunction pages 11-16, ros2025bluntingmycfunction pages 7-11, ros2025bluntingmycfunction pages 16-19) |
| Mechanism | ATP/ADP-dependent conformational cycle; recent cryo-EM supports an "airlock"-like gating mechanism that accepts folded RISP in the ATP-bound state and releases it upon hydrolysis. | (ros2025bluntingmycfunction pages 11-16) |
| Pathway context | Essential assembly factor for mitochondrial Complex III (cytochrome bc1); required for formation of catalytically competent CIII and thus for the Q-cycle electron transfer. | (ros2025bluntingmycfunction pages 7-11, banerjee2024hepaticmitochondrialrespiration pages 1-4) |
| Human disease associations | Pathogenic variants cause a spectrum including GRACILE syndrome (founder p.S78G), Björnstad syndrome, and heterogeneous phenotypes from CIII deficiency. | (ros2025bluntingmycfunction pages 16-19, ros2025bluntingmycfunction pages 7-11) |
| Recent advances (2023–2024) | Preclinical Bcs1l p.S78G mouse studies show hepatocyte-targeted rAAV Bcs1l restores hepatic CIII and metabolism, improves thermoregulation (AOX studies) and can ~double survival in treated cohorts. | (banerjee2024hepaticmitochondrialrespiration pages 1-4, banerjee2025hepaticgenereplacement pages 1-5, banerjee2025hepaticgenereplacement pages 14-17) |
| Real-world implementations | Preclinical rAAV-based, hepatocyte-directed gene replacement (AAT promoter; CAG tested) and PiggyBac co-integration strategies have been applied in mouse GRACILE models. | (banerjee2025hepaticgenereplacement pages 1-5, banerjee2025hepaticgenereplacement pages 5-8, banerjee2024hepaticmitochondrialrespiration pages 1-4) |
| Key data points / statistics | AAT-Bcs1l hepatocyte rescue: ~15-fold hepatic Bcs1l mRNA at P28; hepatic CIII activity restored to ~74% of WT; median survival extended to ~58 days in treated mice. | (banerjee2025hepaticgenereplacement pages 1-5, banerjee2025hepaticgenereplacement pages 5-8) |
| Open questions / challenges | Extrahepatic disease progression limits lifespan despite hepatic rescue; rAAV episomal dilution limits durability—multi-tissue or durable delivery approaches needed. | (banerjee2025hepaticgenereplacement pages 5-8, banerjee2025hepaticgenereplacement pages 14-17) |
Table: A concise, evidence-linked summary table of BCS1L biological identity, mechanism, disease links, recent preclinical therapeutic advances, and outstanding challenges; useful as a quick-reference for researchers and clinicians (context IDs cite the gathered evidence).
Notes on verification and ambiguity
- The symbol BCS1L unambiguously corresponds to the human mitochondrial assembly factor BCS1L described here; no conflicting gene of the same symbol was identified in the evidence set. Domain architecture and family classification (AAA+ ATPase, BCS1 subfamily) match UniProt Q9Y276 and are consistent with recent mechanistic literature. (ros2025bluntingmycfunction pages 11-16)
References with URLs and dates (where available)
- Hepatocyte-directed gene replacement and thermoregulation in Bcs1l p.S78G mice: bioRxiv, posted Nov 2024. https://doi.org/10.1101/2024.09.23.612616 (banerjee2024hepaticmitochondrialrespiration pages 1-4)
- Hepatic gene replacement extends survival, restores CIII activity and metabolism in GRACILE model: preprint, posted Sep 2025. https://doi.org/10.1101/2025.09.23.677965 (banerjee2025hepaticgenereplacement pages 1-5, banerjee2025hepaticgenereplacement pages 14-17, banerjee2025hepaticgenereplacement pages 5-8)
- Mechanistic summary of BCS1L as heptameric AAA+ ATPase/translocase for folded UQCRFS1 and disease spectrum overview: 2025 source summarizing 2023–2024 structural advances and clinical entities. (ros2025bluntingmycfunction pages 11-16, ros2025bluntingmycfunction pages 16-19, ros2025bluntingmycfunction pages 7-11)
Citations
- Mechanism, domains, heptameric assembly, UQCRFS1 client and “airlock” model: (ros2025bluntingmycfunction pages 11-16)
- CIII composition/function context and UQCRFS1 role: (ros2025bluntingmycfunction pages 7-11)
- Disease spectrum including GRACILE (p.S78G) and Björnstad; mouse model features and presymptomatic window; dietary/MYC modulation context: (ros2025bluntingmycfunction pages 16-19, ros2025bluntingmycfunction pages 7-11)
- rAAV hepatocyte Bcs1l rescue: prevention of hepatopathy, restored hepatic CIII function, survival extension, durability limits and PiggyBac findings: (banerjee2024hepaticmitochondrialrespiration pages 1-4, banerjee2025hepaticgenereplacement pages 1-5, banerjee2025hepaticgenereplacement pages 5-8)
- Thermoregulation and AOX rescue; thermoneutrality effects: (banerjee2024hepaticmitochondrialrespiration pages 1-4)
References
(ros2025bluntingmycfunction pages 11-16): O Ros. Blunting myc function in mitochondrial complex iii deficient mice with a hypomorphic myc allele. Unknown journal, 2025.
(ros2025bluntingmycfunction pages 7-11): O Ros. Blunting myc function in mitochondrial complex iii deficient mice with a hypomorphic myc allele. Unknown journal, 2025.
(ros2025bluntingmycfunction pages 16-19): O Ros. Blunting myc function in mitochondrial complex iii deficient mice with a hypomorphic myc allele. Unknown journal, 2025.
(banerjee2024hepaticmitochondrialrespiration pages 1-4): Rishi Banerjee, Divya Upadhyay, Tomáš Zarybnický, Christa Kietz, Satu Kuure, Vineta Fellman, Janne Purhonen, and Jukka Kallijärvi. Hepatic mitochondrial respiration is crucial for euthermia in complex iii-deficient mice with impaired brown adipose tissue thermogenesis. bioRxiv, Nov 2024. URL: https://doi.org/10.1101/2024.09.23.612616, doi:10.1101/2024.09.23.612616. This article has 2 citations and is from a poor quality or predatory journal.
(banerjee2025hepaticgenereplacement pages 1-5): Rishi Banerjee, Janne Purhonen, Nasrin Sultana, Christa Kietz, Vineta Fellman, and Jukka Kallijärvi. Hepatic gene replacement restores energy metabolism and doubles the survival in mouse model of gracile syndrome, a neonatal mitochondrial disease. BioRxiv, Sep 2025. URL: https://doi.org/10.1101/2025.09.23.677965, doi:10.1101/2025.09.23.677965. This article has 0 citations and is from a poor quality or predatory journal.
(banerjee2025hepaticgenereplacement pages 5-8): Rishi Banerjee, Janne Purhonen, Nasrin Sultana, Christa Kietz, Vineta Fellman, and Jukka Kallijärvi. Hepatic gene replacement restores energy metabolism and doubles the survival in mouse model of gracile syndrome, a neonatal mitochondrial disease. BioRxiv, Sep 2025. URL: https://doi.org/10.1101/2025.09.23.677965, doi:10.1101/2025.09.23.677965. This article has 0 citations and is from a poor quality or predatory journal.
(banerjee2025hepaticgenereplacement pages 14-17): Rishi Banerjee, Janne Purhonen, Nasrin Sultana, Christa Kietz, Vineta Fellman, and Jukka Kallijärvi. Hepatic gene replacement restores energy metabolism and doubles the survival in mouse model of gracile syndrome, a neonatal mitochondrial disease. BioRxiv, Sep 2025. URL: https://doi.org/10.1101/2025.09.23.677965, doi:10.1101/2025.09.23.677965. This article has 0 citations and is from a poor quality or predatory journal.
id: Q9Y276
gene_symbol: BCS1L
product_type: PROTEIN
status: COMPLETE
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: >-
BCS1L (Mitochondrial chaperone BCS1) is a conserved AAA-type ATPase that functions as a
dedicated assembly factor for mitochondrial respiratory chain Complex III (cytochrome bc1
complex). BCS1L forms a heptameric ring embedded in the mitochondrial inner membrane and
uses ATP hydrolysis to translocate the fully folded Rieske iron-sulfur protein (UQCRFS1)
from the matrix across the inner membrane into the intermembrane space (IMS), where it is
incorporated into pre-Complex III. This is an essential late step in CIII biogenesis.
BCS1L is NOT a structural subunit of the mature Complex III; it is an assembly factor that
acts transiently during biogenesis. The protein has a single N-terminal transmembrane helix,
a BCS1-specific middle domain, and a C-terminal AAA ATPase domain. It also interacts with
LETM1 and influences LETM1 complex formation. Loss-of-function mutations in BCS1L cause
a spectrum of diseases including GRACILE syndrome (growth retardation, aminoaciduria,
cholestasis, iron overload, lactic acidosis, and early death), Bjornstad syndrome
(sensorineural hearing loss and pili torti), and mitochondrial complex III deficiency
nuclear type 1 (MC3DN1). BCS1L is the human ortholog of yeast Bcs1.
existing_annotations:
# ===== ANNOTATION 1: GO:0032979 (BP) - IBA =====
- term:
id: GO:0032979
label: protein insertion into mitochondrial inner membrane from matrix
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
BCS1L translocates the folded Rieske iron-sulfur protein (UQCRFS1) from the
mitochondrial matrix across the inner membrane for incorporation into pre-Complex III.
This function is conserved from yeast Bcs1 to human BCS1L. The IBA annotation to
GO:0032979 (protein insertion into mitochondrial inner membrane from matrix)
accurately captures this core translocase function. The deep research review confirms
BCS1L as an "ATP-driven translocase/chaperone that translocates the folded Rieske
Fe-S protein (UQCRFS1 / RISP) from the matrix into the IMS"
(file:human/BCS1L/BCS1L-deep-research-falcon.md). UniProt describes it as a
"Chaperone necessary for the incorporation of Rieske iron-sulfur protein UQCRFS1
into the mitochondrial respiratory chain complex III" (PMID:11528392, PMID:9878253).
action: ACCEPT
reason: >-
This IBA annotation is well-supported and at the correct level of specificity.
BCS1L's primary molecular mechanism is the ATP-driven translocation of the folded
UQCRFS1 from the matrix side into/through the inner membrane. This is the defining
translocase activity of BCS1L and is phylogenetically conserved from yeast to human.
The annotation is well-placed: BCS1L does insert a protein (UQCRFS1) into or through
the mitochondrial inner membrane from the matrix.
supported_by:
- reference_id: file:human/BCS1L/BCS1L-deep-research-falcon.md
supporting_text: >-
ATP-driven translocase/chaperone that translocates the folded Rieske
Fe-S protein (UQCRFS1 / RISP) from the matrix into the IMS
- reference_id: PMID:9878253
supporting_text: >-
In yeast, BCS1 is involved mainly in the assembly of complex III
# ===== ANNOTATION 2: GO:0034551 (BP) - IBA =====
- term:
id: GO:0034551
label: mitochondrial respiratory chain complex III assembly
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
BCS1L is a well-established assembly factor for mitochondrial Complex III. The
phylogenetic inference from yeast Bcs1 through to human BCS1L is strongly supported.
UniProt describes BCS1L as a "Chaperone necessary for the incorporation of Rieske
iron-sulfur protein UQCRFS1 into the mitochondrial respiratory chain complex III"
(PMID:11528392, PMID:9878253). PMID:9878253 identified BCS1L as the human ortholog
of yeast BCS1, "involved mainly in the assembly of complex III." Reactome also
curates BCS1L under Complex III assembly (R-HSA-9865881). This is the core biological
process of BCS1L.
action: ACCEPT
reason: >-
Mitochondrial respiratory chain complex III assembly is the core biological process
for BCS1L. This IBA annotation is at the correct level of specificity and is supported
by extensive experimental and phylogenetic evidence. BCS1L inserts the Rieske Fe-S
protein into pre-CIII, which is an essential step in CIII assembly.
supported_by:
- reference_id: PMID:9878253
supporting_text: >-
In yeast, BCS1 is involved mainly in the assembly of complex III
- reference_id: Reactome:R-HSA-9865881
supporting_text: >-
Assembly of the cytochrome c (cytochrome bc1) reductase (Complex III) was mainly
investigated in yeast
- reference_id: file:human/BCS1L/BCS1L-deep-research-falcon.md
supporting_text: >-
Essential assembly factor for mitochondrial Complex III (cytochrome bc1); required
for formation of catalytically competent CIII and thus for the Q-cycle electron
transfer
# ===== ANNOTATION 3: GO:0005743 (CC) - IBA =====
- term:
id: GO:0005743
label: mitochondrial inner membrane
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
BCS1L is anchored in the mitochondrial inner membrane via a single N-terminal
transmembrane helix (residues 16-32 per UniProt). UniProt annotates BCS1L to
"Mitochondrion inner membrane; Single-pass membrane protein"
(PMID:18628306, PMID:9878253). The heptameric BCS1L ring spans the inner membrane
with its AAA domain projecting into the matrix. The IBA annotation correctly captures
this well-established localization.
action: ACCEPT
reason: >-
Mitochondrial inner membrane localization is universally agreed upon for BCS1L. The
protein has a single transmembrane helix and the UniProt record confirms inner
membrane localization with experimental evidence from multiple studies. The IBA
annotation is phylogenetically well-supported and at the correct level of specificity.
supported_by:
- reference_id: PMID:18628306
supporting_text: >-
LETM1 is a mitochondrial inner-membrane protein ... LETM1 was co-precipitated
with BCS1L
- reference_id: PMID:9878253
supporting_text: >-
Mitochondrial targeting of the human gene products, suggested by computer analysis
of the protein sequences, was confirmed by an in vitro import and
protease-protection assay
# ===== ANNOTATION 4: GO:0000166 (MF) - IEA =====
- term:
id: GO:0000166
label: nucleotide binding
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: >-
BCS1L contains a conserved AAA ATPase domain with a P-loop (Walker A motif) at
residues 230-237 that binds ATP (UniProt BINDING annotation). The IEA annotation
to nucleotide binding (GO:0000166) via UniProt keyword mapping is technically correct
but very broad. More specific ATP binding (GO:0005524) and ATP hydrolysis activity
(GO:0016887) annotations are already present.
action: ACCEPT
reason: >-
While very general, this IEA annotation is technically correct. BCS1L is an
AAA-type ATPase that binds nucleotides (specifically ATP). More specific annotations
are present in the set (GO:0005524 ATP binding, GO:0016887 ATP hydrolysis activity).
It is acceptable for an IEA to be broader than what is established by more specific
evidence.
# ===== ANNOTATION 5: GO:0005524 (MF) - IEA =====
- term:
id: GO:0005524
label: ATP binding
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: >-
BCS1L contains a well-characterized AAA ATPase domain with a P-loop/Walker A motif
(residues 230-237) that binds ATP (UniProt). The InterPro domains IPR003959
(ATPase_AAA_core) and IPR003960 (ATPase_AAA_CS) confirm ATP binding capability.
Cryo-EM structures demonstrate ATP/ADP cycling in the heptameric ring during the
translocation mechanism (file:human/BCS1L/BCS1L-deep-research-falcon.md). The
UniProt EC number is 3.6.1.- (by similarity to yeast P32839).
action: ACCEPT
reason: >-
ATP binding is a well-established property of BCS1L as an AAA-type ATPase. The
annotation is supported by domain architecture, structural data, and evolutionary
conservation. This is a core molecular function of BCS1L.
supported_by:
- reference_id: file:human/BCS1L/BCS1L-deep-research-falcon.md
supporting_text: >-
ATP binding opens a cavity to accommodate the folded, Fe2S2-containing UQCRFS1;
ATP hydrolysis drives conformational changes that gate and release the client
# ===== ANNOTATION 6: GO:0005743 (CC) - IEA =====
- term:
id: GO:0005743
label: mitochondrial inner membrane
evidence_type: IEA
original_reference_id: GO_REF:0000044
review:
summary: >-
This IEA annotation from UniProt Subcellular Location vocabulary mapping is consistent
with all other evidence. UniProt explicitly annotates BCS1L to the mitochondrion inner
membrane as a single-pass membrane protein (PMID:18628306, PMID:9878253). This
duplicates the IBA annotation (GO_REF:0000033) for the same term but via independent
evidence.
action: ACCEPT
reason: >-
Consistent with the IBA annotation and the well-established inner membrane
localization of BCS1L. Duplicate annotations from different evidence sources are
acceptable. UniProt's subcellular location mapping is correct here.
# ===== ANNOTATION 7: GO:0016787 (MF) - IEA =====
- term:
id: GO:0016787
label: hydrolase activity
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: >-
BCS1L hydrolyzes ATP (EC 3.6.1.-) as part of its AAA-type ATPase mechanism.
Hydrolase activity (GO:0016787) is the correct broad parent for this. The annotation
from UniProt keyword mapping is technically correct but very broad. More specific
ATP hydrolysis activity (GO:0016887) is already present.
action: ACCEPT
reason: >-
While very general, this IEA annotation is technically correct. BCS1L is an ATPase
that catalyzes the hydrolysis of ATP. More specific annotations (GO:0016887 ATP
hydrolysis activity) are present. It is acceptable for IEA annotations to be
broader than what is established by more specific evidence.
# ===== ANNOTATION 8: GO:0016887 (MF) - IEA =====
- term:
id: GO:0016887
label: ATP hydrolysis activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: >-
BCS1L is a member of the AAA ATPase family and uses ATP hydrolysis to power the
translocation of the folded Rieske protein across the inner membrane. UniProt assigns
EC 3.6.1.- (by similarity to yeast Bcs1, P32839). The deep research review describes
an "ATP/ADP-dependent conformational cycle" where "ATP hydrolysis drives conformational
changes that gate and release the client to the IMS" (file:human/BCS1L/BCS1L-deep-research-falcon.md).
This is a core molecular function of BCS1L.
action: ACCEPT
reason: >-
ATP hydrolysis activity is a core molecular function of BCS1L. It uses ATP hydrolysis
to drive translocation of UQCRFS1 across the inner membrane. The annotation is
well-supported by domain architecture (AAA ATPase domain), EC classification, and
mechanistic studies. Per the GO note on this term, BCS1L should also ideally be
annotated to a child of ATP-dependent activity (GO:0140657) to capture its overall
function.
supported_by:
- reference_id: file:human/BCS1L/BCS1L-deep-research-falcon.md
supporting_text: >-
ATP hydrolysis drives conformational changes that gate and release the client
to the IMS while preserving membrane integrity
# ===== ANNOTATION 9: GO:0034551 (BP) - IEA =====
- term:
id: GO:0034551
label: mitochondrial respiratory chain complex III assembly
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: >-
This IEA annotation via ARBA machine learning correctly identifies the core biological
process of BCS1L. The annotation is consistent with the IBA and IMP annotations for the
same term already present, and is well-supported by all evidence reviewed.
action: ACCEPT
reason: >-
The ARBA-derived IEA annotation is correct. CIII assembly is the core function of
BCS1L. This is redundant with the IBA and IMP annotations but not incorrect.
Multiple independent evidence lines supporting the same annotation are acceptable.
# ===== ANNOTATION 10: GO:0005739 (CC) - IEA =====
- term:
id: GO:0005739
label: mitochondrion
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: >-
BCS1L is a mitochondrial protein. This broader CC annotation (mitochondrion rather
than mitochondrial inner membrane) is technically correct. More specific inner membrane
annotations are already present from IBA and IEA evidence.
action: ACCEPT
reason: >-
Mitochondrial localization is universally agreed upon. While the more specific inner
membrane annotation is also present, this broader IEA annotation is acceptable as
it provides independent automated evidence for the mitochondrial localization.
# ===== ANNOTATION 11: GO:0005739 (CC) - HTP =====
- term:
id: GO:0005739
label: mitochondrion
evidence_type: HTP
original_reference_id: PMID:34800366
review:
summary: >-
BCS1L was identified as part of the high-confidence human mitochondrial proteome by
Morgenstern et al. (2021, PMID:34800366), a comprehensive quantitative proteomics
study. This HTP evidence provides independent experimental confirmation of
mitochondrial localization via mass spectrometry-based identification.
action: ACCEPT
reason: >-
The HTP annotation is based on large-scale quantitative proteomics and is consistent
with all other evidence for BCS1L mitochondrial localization. While less specific than
the inner membrane annotation, it provides independent experimental support.
supported_by:
- reference_id: PMID:34800366
supporting_text: >-
Quantitative high-confidence human mitochondrial proteome
# ===== ANNOTATION 12: GO:0005739 (CC) - IDA =====
- term:
id: GO:0005739
label: mitochondrion
evidence_type: IDA
original_reference_id: PMID:9878253
review:
summary: >-
Petruzzella et al. (1998, PMID:9878253) confirmed mitochondrial targeting of BCS1L
using an in vitro import and protease-protection assay. The abstract states:
"Mitochondrial targeting of the human gene products, suggested by computer analysis
of the protein sequences, was confirmed by an in vitro import and
protease-protection assay." This is direct experimental evidence for mitochondrial
localization.
action: ACCEPT
reason: >-
This is strong IDA evidence from the founding characterization of human BCS1L.
The in vitro import and protease-protection assay directly demonstrates that BCS1L
is imported into mitochondria. This is consistent with all other localization data.
supported_by:
- reference_id: PMID:9878253
supporting_text: >-
Mitochondrial targeting of the human gene products, suggested by computer analysis
of the protein sequences, was confirmed by an in vitro import and
protease-protection assay
# ===== ANNOTATION 13: GO:0005515 (MF) - IPI =====
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:18628306
review:
summary: >-
This IPI annotation is based on the physical interaction between BCS1L and LETM1
(UniProtKB:O95202), identified by Tamai et al. (2008, PMID:18628306). The abstract
states: "LETM1 was co-precipitated with BCS1L and formation of the LETM1 complex
depended on BCS1L levels, suggesting that BCS1L stimulates the assembly of the
LETM1 complex." While the interaction is biologically meaningful, the term 'protein
binding' (GO:0005515) is uninformative per GO curation guidelines.
action: MARK_AS_OVER_ANNOTATED
reason: >-
The term 'protein binding' (GO:0005515) is uninformative per GO curation guidelines.
The BCS1L-LETM1 interaction is experimentally validated and biologically interesting,
but this generic MF term does not convey any specific information about BCS1L's
actual molecular function. The biological significance of this interaction is better
captured by the process annotation for mitochondrion organization (GO:0007005).
A more informative MF annotation would describe BCS1L's translocase/chaperone activity.
supported_by:
- reference_id: PMID:18628306
supporting_text: >-
LETM1 was co-precipitated with BCS1L and formation of the LETM1 complex depended
on BCS1L levels, suggesting that BCS1L stimulates the assembly of the LETM1 complex
# ===== ANNOTATION 14: GO:0034551 (BP) - IMP =====
- term:
id: GO:0034551
label: mitochondrial respiratory chain complex III assembly
evidence_type: IMP
original_reference_id: PMID:18628306
review:
summary: >-
Tamai et al. (2008, PMID:18628306) demonstrated that BCS1L knockdown caused
"disassembly of the respiratory chains." The abstract states: "BCS1L knockdown
caused disassembly of the respiratory chains as well as LETM1 downregulation and
induced distinct changes in mitochondrial morphology." Additionally, the R155P
(MC3DN1) variant was characterized and found to abolish interaction with LETM1.
This IMP evidence from mutant/knockdown phenotype confirms BCS1L's role in CIII
assembly.
action: ACCEPT
reason: >-
This is strong IMP evidence demonstrating that loss of BCS1L function causes
disassembly of the respiratory chains, including Complex III. This directly supports
BCS1L's role as a CIII assembly factor. Combined with the IBA and IEA annotations,
this provides multiple independent evidence lines for the core function.
supported_by:
- reference_id: PMID:18628306
supporting_text: >-
BCS1L knockdown caused disassembly of the respiratory chains as well as LETM1
downregulation and induced distinct changes in mitochondrial morphology
# ===== ANNOTATION 15: GO:0005739 (CC) - IDA =====
- term:
id: GO:0005739
label: mitochondrion
evidence_type: IDA
original_reference_id: PMID:18628306
review:
summary: >-
Tamai et al. (2008, PMID:18628306) studied BCS1L localization in HeLa cells and
confirmed it is a mitochondrial inner-membrane protein that interacts with LETM1.
The title itself describes BCS1L as "the mitochondrial protein LETM1...interacts
with the AAA-ATPase BCS1L" and the study performed subcellular localization
experiments placing BCS1L in mitochondria.
action: ACCEPT
reason: >-
Independent IDA evidence from Tamai et al. (2008) confirming mitochondrial
localization of BCS1L. Consistent with all other evidence. Multiple IDA annotations
from different studies for the same term are acceptable.
supported_by:
- reference_id: PMID:18628306
supporting_text: >-
LETM1 is a mitochondrial inner-membrane protein ... LETM1 was co-precipitated
with BCS1L
# ===== ANNOTATION 16: GO:0007005 (BP) - IMP =====
- term:
id: GO:0007005
label: mitochondrion organization
evidence_type: IMP
original_reference_id: PMID:18628306
review:
summary: >-
Tamai et al. (2008, PMID:18628306) demonstrated that BCS1L knockdown caused
"distinct changes in mitochondrial morphology" and affected LETM1 levels and complex
formation. LETM1 knockdown itself caused "mitochondrial swelling and cristae
disorganization." Since BCS1L knockdown leads to LETM1 downregulation, and LETM1 is
required for maintaining mitochondrial tubular networks, BCS1L indirectly affects
mitochondrion organization. However, this is a secondary pleiotropic consequence of
BCS1L loss rather than a core function. BCS1L's core function is CIII assembly,
and disruption of respiratory chain complexes leads to downstream mitochondrial
morphology defects.
action: KEEP_AS_NON_CORE
reason: >-
While BCS1L knockdown does cause changes in mitochondrial morphology, this is a
downstream consequence of respiratory chain disassembly and LETM1 downregulation,
not a core direct function of BCS1L. BCS1L's primary role is as a CIII assembly
factor and UQCRFS1 translocase. The mitochondrion organization phenotype is a
pleiotropic secondary effect. The annotation is not wrong but should be flagged as
non-core.
supported_by:
- reference_id: PMID:18628306
supporting_text: >-
BCS1L knockdown caused disassembly of the respiratory chains as well as LETM1
downregulation and induced distinct changes in mitochondrial morphology
# ===== ANNOTATION 17: GO:0032981 (BP) - IMP =====
- term:
id: GO:0032981
label: mitochondrial respiratory chain complex I assembly
evidence_type: IMP
original_reference_id: PMID:18628306
review:
summary: >-
Tamai et al. (2008, PMID:18628306) reported that BCS1L knockdown caused
"disassembly of the respiratory chains." This broad statement encompasses Complex I,
III, and IV. However, BCS1L is specifically a Complex III assembly factor that
translocates the Rieske Fe-S protein. Loss of BCS1L directly impairs CIII assembly,
and since respiratory chain complexes can form supercomplexes (respirasomes),
loss of CIII can secondarily destabilize CI and CIV. There is no evidence that
BCS1L directly participates in Complex I assembly. The CI assembly defect observed
upon BCS1L knockdown is an indirect pleiotropic consequence.
action: MARK_AS_OVER_ANNOTATED
reason: >-
BCS1L is not a Complex I assembly factor. It is a Complex III assembly factor.
The observed effect on Complex I assembly upon BCS1L knockdown is a secondary
consequence of CIII destabilization, which in turn destabilizes supercomplexes
containing CI. Annotating BCS1L to CI assembly conflates indirect downstream
effects with direct function. This is an over-annotation that could mislead users
about BCS1L's actual role.
supported_by:
- reference_id: PMID:18628306
supporting_text: >-
BCS1L knockdown caused disassembly of the respiratory chains
- reference_id: file:human/BCS1L/BCS1L-deep-research-falcon.md
supporting_text: >-
Essential assembly factor for mitochondrial Complex III (cytochrome bc1); required
for formation of catalytically competent CIII
# ===== ANNOTATION 18: GO:0033617 (BP) - IMP =====
- term:
id: GO:0033617
label: mitochondrial respiratory chain complex IV assembly
evidence_type: IMP
original_reference_id: PMID:18628306
review:
summary: >-
Tamai et al. (2008, PMID:18628306) reported that BCS1L knockdown caused
"disassembly of the respiratory chains." This broad disassembly phenotype was
interpreted as affecting Complex IV assembly as well. However, BCS1L is specifically
a Complex III assembly factor. There is no evidence that BCS1L directly participates
in Complex IV biogenesis. The CIV assembly defect observed upon BCS1L knockdown is
an indirect consequence of CIII destabilization, since CI, CIII, and CIV form
supercomplexes and loss of one component can destabilize others. This is analogous
to how SURF1 (a CIV assembly factor) mutations affect other complexes secondarily.
action: MARK_AS_OVER_ANNOTATED
reason: >-
BCS1L is not a Complex IV assembly factor. It is a Complex III assembly factor.
The observed effect on Complex IV assembly upon BCS1L knockdown is a secondary
consequence of CIII destabilization affecting supercomplex stability. Annotating
BCS1L to CIV assembly conflates indirect downstream effects with direct function.
This is an over-annotation analogous to the CI assembly annotation.
supported_by:
- reference_id: PMID:18628306
supporting_text: >-
BCS1L knockdown caused disassembly of the respiratory chains
- reference_id: file:human/BCS1L/BCS1L-deep-research-falcon.md
supporting_text: >-
Essential assembly factor for mitochondrial Complex III (cytochrome bc1)
# ===== ANNOTATION 19: GO:0045275 (CC) - TAS =====
- term:
id: GO:0045275
label: respiratory chain complex III
evidence_type: TAS
original_reference_id: PMID:9878253
review:
summary: >-
This TAS annotation places BCS1L as part_of "respiratory chain complex III"
(GO:0045275). The GOA file uses the qualifier "part_of." GO:0045275 is defined as
"A protein complex that transfers electrons from ubiquinol to cytochrome c and
translocates two protons across a membrane." BCS1L is NOT a structural subunit of
the mature Complex III. It is an assembly factor that transiently associates with
pre-Complex III during biogenesis but is not a component of the final holoenzyme.
The original paper (PMID:9878253) describes BCS1 as "involved in the assembly of
complex III" in yeast, not as a subunit. UniProt describes BCS1L as a "Chaperone
necessary for the incorporation of Rieske iron-sulfur protein UQCRFS1 into the
mitochondrial respiratory chain complex III," clearly distinguishing it from a
structural subunit. The Reactome pathway (R-HSA-9865881) places BCS1L as an
assembly factor, not as a component of the mature complex.
action: REMOVE
reason: >-
BCS1L is NOT a structural subunit of respiratory chain complex III. It is a transient
assembly factor that facilitates UQCRFS1 incorporation into pre-CIII but is not
part of the mature complex. The "part_of" qualifier in GOA makes this annotation
explicitly incorrect -- BCS1L is not part of the CIII holoenzyme. The founding paper
(PMID:9878253) describes BCS1 as involved in "assembly" of CIII, not as a component.
This annotation likely arose from confusion between an assembly factor and a
structural subunit. The correct annotations for BCS1L are to CIII assembly
(GO:0034551, already present) and to the mitochondrial inner membrane (GO:0005743,
already present). This parallels the SURF1 case where annotation to
"respiratory chain complex" was modified because SURF1 is an assembly factor,
not a structural subunit.
supported_by:
- reference_id: PMID:9878253
supporting_text: >-
In yeast, BCS1 is involved mainly in the assembly of complex III
- reference_id: Reactome:R-HSA-9865881
supporting_text: >-
Mutations in nuclear genes coding for subunits of Complex III, as well as assembly
factors, can cause complex III deficiency
- reference_id: file:human/BCS1L/BCS1L-deep-research-falcon.md
supporting_text: >-
BCS1L is best understood as a dedicated AAA+ protein translocase that recognizes
and translocates folded, cofactor-loaded UQCRFS1 across/into the IMS side of
pre-complex III
# ===== NEW ANNOTATION 1: GO:0008320 (MF) - protein transmembrane transporter activity =====
- term:
id: GO:0008320
label: protein transmembrane transporter activity
evidence_type: ISS
original_reference_id: PMID:37821516
review:
summary: >-
BCS1L functions as an ATP-driven transmembrane translocase that moves the folded
Rieske Fe-S protein (UQCRFS1) from the matrix across the inner membrane into the
intermembrane space. This translocase function is conserved from yeast Bcs1 to
human BCS1L. GO:0008320 (protein transmembrane transporter activity) is defined as
"Enables the transfer of a protein from one side of a membrane to the other." This
accurately describes BCS1L's core molecular function. The deep research review
describes BCS1L as a "specialized transmembrane protein translocase for a folded
cofactor-containing substrate" with an "ATP-coupled airlock-like gating mechanism."
This annotation is missing from the current set and would capture the specific MF
of BCS1L that goes beyond simple ATP hydrolysis.
action: NEW
reason: >-
The current annotation set lacks a specific MF annotation capturing BCS1L's
translocase activity. While ATP hydrolysis (GO:0016887) and ATP binding (GO:0005524)
are present, these describe the energy source, not the actual function. GO:0008320
(protein transmembrane transporter activity) would capture what BCS1L actually does
with the energy from ATP hydrolysis: it translocates a protein (UQCRFS1) across
the inner membrane. This is more informative than the generic protein binding
currently annotated.
supported_by:
- reference_id: PMID:37821516
supporting_text: >-
Bcs1, a homo-heptameric transmembrane AAA-ATPase, facilitates folded Rieske
iron-sulfur protein translocation across the inner mitochondrial membrane
- reference_id: file:human/BCS1L/BCS1L-deep-research-falcon.md
supporting_text: >-
BCS1L is best understood as a dedicated AAA+ protein translocase that recognizes
and translocates folded, cofactor-loaded UQCRFS1 across/into the IMS side of
pre-complex III. This specialized role distinguishes it from general chaperones
references:
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000043
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
findings: []
- id: GO_REF:0000044
title: >-
Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
vocabulary mapping, accompanied by conservative changes to GO terms applied by
UniProt
findings: []
- id: GO_REF:0000117
title: Electronic Gene Ontology annotations created by ARBA machine learning models
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: PMID:9878253
title: >-
Identification and characterization of human cDNAs specific to BCS1, PET112,
SCO1, COX15, and COX11, five genes involved in the formation and function of the
mitochondrial respiratory chain.
findings:
- statement: >-
Founding paper identifying human BCS1L as the ortholog of yeast BCS1, involved in
Complex III assembly. Mitochondrial targeting confirmed by in vitro import and
protease-protection assay.
supporting_text: >-
In yeast, BCS1 is involved mainly in the assembly of complex III...Mitochondrial
targeting of the human gene products, suggested by computer analysis of the protein
sequences, was confirmed by an in vitro import and protease-protection assay
- id: PMID:11528392
title: >-
A mutant mitochondrial respiratory chain assembly protein causes complex III
deficiency in patients with tubulopathy, encephalopathy and liver failure.
findings:
- statement: >-
First identification of BCS1L mutations in patients with complex III deficiency.
Established BCS1L as an assembly protein for Complex III.
supporting_text: >-
So far only one such gene, BCS1L, has been identified in human. BCS1L represents,
therefore, an obvious candidate gene in CIII deficiency. Here, we report BCS1L
mutations in six patients
- id: PMID:18628306
title: >-
Characterization of the mitochondrial protein LETM1, which maintains the
mitochondrial tubular shapes and interacts with the AAA-ATPase BCS1L.
findings:
- statement: >-
BCS1L interacts with LETM1 and BCS1L levels influence LETM1 complex formation.
BCS1L knockdown caused disassembly of the respiratory chains, LETM1 downregulation,
and distinct changes in mitochondrial morphology. The R155P MC3DN1 variant abolishes
interaction with LETM1.
supporting_text: >-
LETM1 was co-precipitated with BCS1L and formation of the LETM1 complex depended
on BCS1L levels, suggesting that BCS1L stimulates the assembly of the LETM1 complex.
BCS1L knockdown caused disassembly of the respiratory chains as well as LETM1
downregulation and induced distinct changes in mitochondrial morphology
- id: PMID:37821516
title: A concerted ATPase cycle of the protein transporter AAA-ATPase Bcs1.
findings:
- statement: >-
Bcs1 is a homo-heptameric transmembrane AAA-ATPase that mediates folded Rieske
iron-sulfur protein translocation across the inner mitochondrial membrane through
a concerted ATPase cycle.
supporting_text: >-
Bcs1, a homo-heptameric transmembrane AAA-ATPase, facilitates folded Rieske
iron-sulfur protein translocation across the inner mitochondrial membrane
- id: PMID:34800366
title: >-
Quantitative high-confidence human mitochondrial proteome and its dynamics in
cellular context.
findings:
- statement: >-
BCS1L was identified as part of the high-confidence human mitochondrial proteome
by quantitative mass spectrometry.
supporting_text: >-
Quantitative high-confidence human mitochondrial proteome
- id: Reactome:R-HSA-9865881
title: Complex III assembly
findings:
- statement: >-
BCS1L is an assembly factor for Complex III. The Reactome pathway describes the
assembly of the cytochrome bc1 reductase (Complex III) and notes that mutations in
assembly factors can cause complex III deficiency.
supporting_text: >-
Mutations in nuclear genes coding for subunits of Complex III, as well as assembly
factors, can cause complex III deficiency
- id: file:human/BCS1L/BCS1L-deep-research-falcon.md
title: Deep research review of BCS1L gene function
findings:
- statement: >-
BCS1L is a dedicated AAA+ protein translocase that uses ATP hydrolysis to
translocate the folded, cofactor-loaded UQCRFS1 (Rieske Fe-S protein) from the
matrix across the inner membrane into the IMS for incorporation into pre-Complex III.
Forms a heptameric ring in the inner membrane. Recent cryo-EM supports an airlock-like
gating mechanism. Mutations cause GRACILE syndrome, Bjornstad syndrome, and MC3DN1.
core_functions:
- molecular_function:
id: GO:0008320
label: protein transmembrane transporter activity
description: >-
BCS1L is an AAA-type ATPase that uses ATP hydrolysis to power the translocation of the
folded Rieske iron-sulfur protein (UQCRFS1) from the mitochondrial matrix across the
inner membrane into the intermembrane space, where UQCRFS1 is incorporated into
pre-Complex III to complete CIII assembly. BCS1L forms a heptameric ring in the inner
membrane, operating via an ATP/ADP-dependent airlock-like gating mechanism. This is
the sole known function of BCS1L -- it is a dedicated CIII assembly factor and UQCRFS1
translocase, not a structural subunit of the mature complex.
directly_involved_in:
- id: GO:0034551
label: mitochondrial respiratory chain complex III assembly
- id: GO:0032979
label: protein insertion into mitochondrial inner membrane from matrix
locations:
- id: GO:0005743
label: mitochondrial inner membrane
supported_by:
- reference_id: PMID:37821516
supporting_text: >-
Bcs1, a homo-heptameric transmembrane AAA-ATPase, facilitates folded Rieske
iron-sulfur protein translocation across the inner mitochondrial membrane
- reference_id: PMID:18628306
supporting_text: >-
BCS1L knockdown caused disassembly of the respiratory chains
- reference_id: file:human/BCS1L/BCS1L-deep-research-falcon.md
supporting_text: >-
BCS1L is best understood as a dedicated AAA+ protein translocase that recognizes
and translocates folded, cofactor-loaded UQCRFS1 across/into the IMS side of
pre-complex III